Table 3.
Correlations of biopsy features with PSA value, placebo group only
| Nonparametric Pearson's Correlation* | ||
|---|---|---|
| Variable | Correlation | p-value |
| Gleason score | 0.28 | < 0.001 |
| Number of cores positive | 0.25 | < 0.001 |
| Percent of cores positive | 0.26 | < 0.001 |
| Greatest linear extent of tumor | 0.28 | < 0.001 |
| Aggregate linear extent of tumor | 0.29 | < 0.001 |
| Bilateral | 0.16 | < 0.001 |
| Perineural invasion | 0.15 | < 0.001 |
| Prostate volume | 0.31 | < 0.001 |
| Insignificant tumor (Criteria 1)1 | −0.32 | <0.001 |
| Insignificant tumor (Criteria 2)2 | −0.34 | <0.001 |
Ranks assigned to PSA values and all linear values; ties broken arbitrarily. Pearson product-moment correlations were calculated on the ranked variables. True dichotomous variables (Bilateral, Perineural invasion, and Insignificant tumor (both criteria)) were not ranked; their correlations were calculated with ranked PSA values.
Stage T1c + PSA density < 0.15 ng/ml/cc + Gleason score ≤6 (no pattern 4 or 5) + tumor limited to < 3 cores + no core with greater than 50% involvement.
Stage T1c + PSA density < 0.15 ng/ml/cc + Gleason score ≤(no pattern 4 or 5) + tumor limited to < 3 mm on 1 core.